To determine the effects of macrophage PPARγ deletion on breast cancer progression, we performed mammary fat pad orthotopic injections of C57BL/6J-compatible mouse breast cancer cells EO771 in female mice, and followed tumor growth by measuring tumor size. Here, PPARG is linked to breast cancer.